Attached files
| file | filename |
|---|---|
| EX-31.1 - EXHIBIT 31.1 - NORTHWEST BIOTHERAPEUTICS INC | tm2023036d1_ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - NORTHWEST BIOTHERAPEUTICS INC | tm2023036d1_ex23-1.htm |
| 10-K/A - FORM 10-K/A - NORTHWEST BIOTHERAPEUTICS INC | tm2023036d1_10ka.htm |
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with this Amendment No. 1 to Annual Report of Northwest Biotherapeutics, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Linda F. Powers, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Date: June 23, 2020
| By: | /s/ Linda F. Powers | ||
| Name: | Linda F. Powers | ||
| Title: | President and Chief Executive Officer | ||
| Principal Executive Officer | |||
| Principal Financial and Accounting Officer | |||
This certification accompanies the Amendment No. 1 to Annual Report on Form 10-K to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Northwest Biotherapeutics, Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Amendment No. 1 to Annual Report on Form 10-K), irrespective of any general incorporation language contained in such filing.